{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:48:58Z","timestamp":1791499738445,"version":"4.3.4"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["12GHSU193"],"award-info":[{"award-number":["12GHSU193"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["08\/US\/B1517"],"award-info":[{"award-number":["08\/US\/B1517"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["06\/IN.1\/B114"],"award-info":[{"award-number":["06\/IN.1\/B114"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.yexcr.2014.07.034","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T19:30:22Z","timestamp":1407267022000},"page":"371-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Paricalcitol protects against TGF-\u03b21-induced fibrotic responses in hypoxia and stabilises HIF-\u03b1 in renal epithelia"],"prefix":"10.1016","volume":"330","author":[{"given":"Karen A.","family":"Nolan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin P.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten C.","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliodhna","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cormac T.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Godson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2014.07.034_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00041552-200405000-00003","article-title":"Mechanisms of tubulointerstitial fibrosis","volume":"13","author":"Iwano","year":"2004","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.yexcr.2014.07.034_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.semnephrol.2007.02.009","article-title":"TGF-beta in renal injury and disease","volume":"27","author":"Bottinger","year":"2007","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib3","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1038\/sj.onc.1208927","article-title":"TGF-beta and epithelial-to-mesenchymal transitions","volume":"24","author":"Zavadil","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2014.07.034_bib4","doi-asserted-by":"crossref","first-page":"I80","DOI":"10.1161\/01.HYP.13.5_Suppl.I80","article-title":"Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up programme. The Hypertension Detection and Follow-up Programme Cooperative Group","volume":"13","author":"Shulman","year":"1989","journal-title":"Hypertension"},{"key":"10.1016\/j.yexcr.2014.07.034_bib5","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1523-1755.2005.09911.x","article-title":"The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease","author":"Remuzzi","year":"2005","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.yexcr.2014.07.034_bib6","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1093\/ndt\/gfs381","article-title":"Inhibitors\/antagonists of TGF-beta system in kidney fibrosis","volume":"27","author":"Yanagita","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yexcr.2014.07.034_bib7","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","article-title":"BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury","volume":"9","author":"Zeisberg","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2014.07.034_bib8","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2215\/CJN.01050207","article-title":"Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis","volume":"2","author":"Cho","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib9","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1681\/ASN.2010101049","article-title":"Pirfenidone for diabetic nephropathy","volume":"22","author":"Sharma","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbadis.2012.01.008","article-title":"Next-generation sequencing identifies TGF-beta1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathy","volume":"1822","author":"Brennan","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2014.07.034_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1196\/annals.1294.016","article-title":"Cadherin switch in tumor progression","volume":"1014","author":"Hazan","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.yexcr.2014.07.034_bib12","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/1078-0432.CCR-07-1263","article-title":"A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer","volume":"13","author":"Gravdal","year":"2007","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.yexcr.2014.07.034_bib13","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2014.07.034_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1681\/ASN.2012060550","article-title":"Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFbetaR1","volume":"24","author":"Brennan","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1681\/ASN.2005070757","article-title":"Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure","volume":"17","author":"Nangaku","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2014.07.034_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrm1366","article-title":"Oxygen sensing by HIF hydroxylases","volume":"5","author":"Schofield","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.yexcr.2014.07.034_bib19","first-page":"3810","article-title":"Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition","volume":"117","author":"Higgins","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yexcr.2014.07.034_bib20","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/ki.2009.62","article-title":"Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition","volume":"75","author":"Sun","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2014.07.034_bib21","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1095\/biolreprod.103.025031","article-title":"Normoxic induction of the hypoxic-inducible factor-1 alpha by interleukin-1 beta involves the extracellular signal-regulated kinase 1\/2 pathway in normal human cytotrophoblast cells","volume":"70","author":"Qian","year":"2004","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.yexcr.2014.07.034_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1158\/1541-7786.MCR-05-0234","article-title":"Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway","volume":"4","author":"Pore","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.yexcr.2014.07.034_bib23","doi-asserted-by":"crossref","first-page":"40112","DOI":"10.1074\/jbc.M206922200","article-title":"Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha","volume":"277","author":"Chan","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2014.07.034_bib24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ki.2010.543","article-title":"Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease","volume":"79","author":"Dusso","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2014.07.034_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/07853890.2010.543923","article-title":"Extra-skeletal effects of vitamin D deficiency in chronic kidney disease","volume":"43","author":"Chonchol","year":"2011","journal-title":"Ann. Med."},{"key":"10.1016\/j.yexcr.2014.07.034_bib26","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1681\/ASN.2007111164","article-title":"Association of oral calcitriol with improved survival in nondialyzed CKD","volume":"19","author":"Shoben","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib27","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/ki.2008.343","article-title":"Oral active vitamin D is associated with improved survival in hemodialysis patients","volume":"74","author":"Naves-Diaz","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2014.07.034_bib28","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/ki.2008.453","article-title":"Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation","volume":"74","author":"Zehnder","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2014.07.034_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/138945011793591572","article-title":"Vitamin D in chronic kidney disease: new potential for intervention","volume":"12","author":"Mirkovic","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.yexcr.2014.07.034_bib30","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.2013030203","article-title":"Active vitamin D treatment for reduction of residual proteinuria: a systematic review","volume":"24","author":"de Borst","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib31","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1093\/ndt\/gfp117","article-title":"Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats","volume":"24","author":"Matsui","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yexcr.2014.07.034_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","article-title":"Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials","volume":"6","author":"Kandula","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib33","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1681\/ASN.2006050520","article-title":"Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy","volume":"17","author":"Tan","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1681\/ASN.2009121236","article-title":"Blockade of Wnt\/beta-catenin signalling by paricalcitol ameliorates proteinuria and kidney injury","volume":"22","author":"He","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib35","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/ki.2010.69","article-title":"Paricalcitol attenuates cyclosporine-induced kidney injury in rats","volume":"77","author":"Park","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2014.07.034_bib36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejphar.2012.03.019","article-title":"Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation","volume":"683","author":"Park","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib37","doi-asserted-by":"crossref","first-page":"e63186","DOI":"10.1371\/journal.pone.0063186","article-title":"Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2014.07.034_bib38","first-page":"2615","article-title":"Multiple post-translational modifications regulate E-cadherin transport during apoptosis","volume":"125","author":"Geng","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2014.07.034_bib39","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1074\/jbc.275.5.3328","article-title":"Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution","volume":"275","author":"Vallorosi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2014.07.034_bib40","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1128\/MCB.01276-10","article-title":"MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia","volume":"31","author":"Bruning","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib41","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/jcb.21545","article-title":"The vitamin D receptor-mediated activation of phosphatidylinositol 3-kinase (PI3Kalpha) plays a role in the 1alpha,25-dihydroxyvitamin D3-stimulated increase in steroid sulphatase activity in myeloid leukaemic cell lines","volume":"103","author":"Hughes","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.yexcr.2014.07.034_bib42","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cellsig.2009.11.009","article-title":"A role for the phosphatidylinositol 3-kinase--protein kinase C zeta--Sp1 pathway in the 1,25-dihydroxyvitamin D3 induction of the 25-hydroxyvitamin D3 24-hydroxylase gene in human kidney cells","volume":"22","author":"Dwivedi","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.yexcr.2014.07.034_bib43","first-page":"900","article-title":"Involvement of PI3-K in neuroprotective effects of the 1,25-dihydroxyvitamin D3 analogue - PRI-2191","volume":"58","author":"Regulska","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.yexcr.2014.07.034_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.RES.0000025269.60668.0F","article-title":"1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase","volume":"91","author":"Rebsamen","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2014.07.034_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5000054","article-title":"Renal fibrosis: new insights into the pathogenesis and therapeutics","volume":"69","author":"Liu","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2014.07.034_bib46","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4161\/cc.7.9.5804","article-title":"Hypoxia-inducible factor signalling in the development of tissue fibrosis","volume":"7","author":"Higgins","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.yexcr.2014.07.034_bib47","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1523-1755.2004.00461.x","article-title":"Transdifferentiation of cultured tubular cells induced by hypoxia","volume":"65","author":"Manotham","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2014.07.034_bib48","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1053\/ajkd.2001.28110","article-title":"Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol","volume":"38","author":"Sprague","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.yexcr.2014.07.034_bib49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.yexcr.2014.07.034_bib50","doi-asserted-by":"crossref","first-page":"F647","DOI":"10.1152\/ajprenal.00090.2011","article-title":"Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy","volume":"302","author":"Sanchez-Nino","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib51","doi-asserted-by":"crossref","DOI":"10.1096\/fj.11-185017","article-title":"Lipoxin A4 and benzo-lipoxin A4 attenuate experimental renal fibrosis","author":"Borgeson","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.yexcr.2014.07.034_bib52","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1172\/JCI43025","article-title":"Epithelial Notch signalling regulates interstitial fibrosis development in the kidneys of mice and humans","volume":"120","author":"Bielesz","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yexcr.2014.07.034_bib53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbadis.2007.09.005","article-title":"Co-regulation of Gremlin and Notch signalling in diabetic nephropathy","volume":"1782","author":"Walsh","year":"2008","journal-title":"Biochim. Biophys. acta"},{"key":"10.1016\/j.yexcr.2014.07.034_bib54","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1128\/MCB.00172-06","article-title":"MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation","volume":"26","author":"Yang","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib55","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signalling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2014.07.034_bib56","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/01.ASN.0000014252.37680.E4","article-title":"Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation","volume":"13","author":"Li","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib57","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1172\/JCI200319270","article-title":"Targeted disruption of TGF-beta1\/Smad3 signalling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction","volume":"112","author":"Sato","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yexcr.2014.07.034_bib58","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2014.07.034_bib59","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1124\/mol.110.070508","article-title":"Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor","volume":"79","author":"Barrett","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib60","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1210\/me.2005-0106","article-title":"Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes","volume":"19","author":"Wang","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2010.06.014","article-title":"1alpha, 25-Dihydroxyvitamin D regulates hypoxia-inducible factor-1alpha in untransformed and Harvey-ras transfected breast epithelial cells","volume":"298","author":"Jiang","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2014.07.034_bib62","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1074\/jbc.M806653200","article-title":"The Akt\/mTOR pathway assures the synthesis of HIF-1alpha protein in a glucose- and reoxygenation-dependent manner in irradiated tumors","volume":"284","author":"Harada","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2014.07.034_bib63","doi-asserted-by":"crossref","first-page":"e33258","DOI":"10.1371\/journal.pone.0033258","article-title":"Hypoxia inducible factor 1-alpha (HIF-1 alpha) is induced during reperfusion after renal ischemia and is critical for proximal tubule cell survival","volume":"7","author":"Conde","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2014.07.034_bib64","doi-asserted-by":"crossref","first-page":"13506","DOI":"10.1074\/jbc.M310164200","article-title":"PI3K\/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation","volume":"279","author":"Zhou","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2014.07.034_bib65","first-page":"1541","article-title":"Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.07.034_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/ndt\/gfp454","article-title":"Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney","volume":"25","author":"Song","year":"2010","journal-title":"Nephro.l Dial. Transplant."},{"key":"10.1016\/j.yexcr.2014.07.034_bib67","doi-asserted-by":"crossref","first-page":"e48952","DOI":"10.1371\/journal.pone.0048952","article-title":"Hypoxia-inducible factor activation protects the kidney from gentamicin-induced acute injury","volume":"7","author":"Ahn","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2014.07.034_bib68","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/ndt\/gfm715","article-title":"Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model","volume":"23","author":"Ohtomo","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yexcr.2014.07.034_bib69","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1440-1797.2011.01498.x","article-title":"Transient hypoxia-inducible factor activation in rat renal ablation and reduced fibrosis with L-mimosine","volume":"17","author":"Yu","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.yexcr.2014.07.034_bib70","doi-asserted-by":"crossref","first-page":"F1023","DOI":"10.1152\/ajprenal.90209.2008","article-title":"Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis","volume":"295","author":"Kimura","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib71","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1186\/1755-1536-5-S1-S16","article-title":"Hypoxia-inducible factor signalling in the development of kidney fibrosis","volume":"5","author":"Haase","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.yexcr.2014.07.034_bib72","doi-asserted-by":"crossref","first-page":"F1223","DOI":"10.1152\/ajprenal.00245.2004","article-title":"Hypoxic induction of Ctgf is directly mediated by Hif-1","volume":"287","author":"Higgins","year":"2004","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib73","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jcp.10065","article-title":"Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the action of TGF-beta1","volume":"191","author":"Falanga","year":"2002","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib74","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/cdd.2008.13","article-title":"Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion","volume":"15","author":"Loor","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2014.07.034_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2013.04.009","article-title":"Targeting the HIF pathway in inflammation and immunity","author":"Scholz","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.yexcr.2014.07.034_bib76","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.gastro.2007.10.012","article-title":"The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis","volume":"134","author":"Cummins","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2014.07.034_bib77","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1053\/j.gastro.2010.06.068","article-title":"Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function","volume":"139","author":"Tambuwala","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2014.07.034_bib78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1254\/jphs.08R09FM","article-title":"Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD","volume":"109","author":"Tanaka","year":"2009","journal-title":"J. Pharmacol. Sci."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482714003255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482714003255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:18:21Z","timestamp":1757996301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482714003255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0014482714003255"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2014.07.034","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paricalcitol protects against TGF-\u03b21-induced fibrotic responses in hypoxia and stabilises HIF-\u03b1 in renal epithelia","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2014.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}